Green Cross Labcell

Green Cross Lab Cell Corporation develops cell therapy products.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Industries / Tags:

Detailed Green Cross Labcell Information

Geographic Data

Green Cross Labcell headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

GC Green Cross Their goal is to contribute to the healthy life of mankind and become a global leader in the healthcare industry. Recent advances in biotechnology have become a good foundation for achieving their goals. The paradigm of medicine is changing. They are shifting from traditional medicines and synthetic medicines to biopharmaceutical development. GC Green Cross Cellular gene therapy, which is the main pipeline of LAPSEL, is expected to enable the treatment of rare and intractable diseases as well as cancer, because of the fundamental treatment of diseases at the gene and cell level. In particular, successful cases such as approval of the first immunotherapeutic drug (CAR-T) in 2017 and the approval of the first gene therapy (Luxturna) were epoch-making events that transformed the expectations they had in mind into reality. Is added.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
6/2020 Artiva Biotherapeutics Series A 0
2/2021 Artiva Biotherapeutics Series B 120M
2/2021 Artiva Biotherapeutics Series B 0
6/2020 Artiva Biotherapeutics Series A 0
Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research